JT002 / Nanjing JSIAMA Biopharma, Shanghai Junshi Bioscience - LARVOL DELTA

Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults (clinicaltrials.gov) - P2 | N=370 | Completed | Sponsor: Shanghai JunTop Biosciences Co., LTD | Active, not recruiting ➔ Completed | Trial completion date: Dec 2025 ➔ May 2025 | Trial primary completion date: Aug 2025 ➔ May 2025

Trial completion • Trial completion date • Trial primary completion date • Allergic Rhinitis • Immunology • Inflammation

Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults (clinicaltrials.gov) - P2 | N=370 | Active, not recruiting | Sponsor: Shanghai JunTop Biosciences Co., LTD | Recruiting ➔ Active, not recruiting

Enrollment closed • Allergic Rhinitis • Immunology • Inflammation